Identification of a Critical Dose Level for Risk Assessment: Developments in Benchmark Dose Analysis of Continuous Endpoints
Authors:
- Salomon SandSSSalomon Sand
- Dietrich von RosenDRDietrich von Rosen
- Katarina VictorinKVKatarina Victorin
- Agneta Falk FilipssonAFAgneta Falk Filipsson
Open Access
- 1 December 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 90 (1) , 241-251
Abstract
The benchmark dose (BMD) method has been recommended to replace the no-observed-adverse-effect-level (NOAEL) approach in health risk assessment of chemical substances. In the present article, developments in BMD analysis from continuous experimental data are proposed. The suggested approach defines the BMD as the dose at which the slope of the S-shaped dose–response relationship changes the most in the low-dose region. This dose resides in a region where the sensitivity to chemical exposure may start to change noticeably. It is shown that the response (defined as a percent change relative to the magnitude, or size, of response) corresponding to the dose where the slope changes the most depends on the geometrical shape of the dose–response curve; the response becomes lower as the curve becomes more asymmetrical and threshold-like in the low-dose region. Given a symmetrical case, described by the Hill function, the response associated with the critical dose level becomes 21% (defined as a percent change relative to the magnitude, or size, of response). According to a limiting case of asymmetry and threshold-like characteristics, reflected by a Gompertz curve, the response corresponding to the dose of interest becomes as low as 7.3% (defined as a percent change relative to the magnitude, or size, of response). Use of a response in the range of 5–10% when estimating the BMD conservatively accounts for uncertainties associated with the proposed strategy, and may be appropriate in a risk assessment point of view. The present investigation also indicated that a BMD defined according to the suggested procedure may be estimated more precisely relative to BMDs defined under other approaches for continuous data.Keywords
This publication has 33 references indexed in Scilit:
- Hazard characterisation of chemicals in food and dietFood and Chemical Toxicology, 2002
- Critical effect sizes in toxicological risk assessment: a comprehensive and critical evaluationEnvironmental Toxicology and Pharmacology, 2001
- Dose–Response Characteristics of Uterine Responses in Rats Exposed to Estrogen AgonistsRegulatory Toxicology and Pharmacology, 1998
- Calculation of Benchmark Doses for Reproductive and Developmental Toxicity Observed after Exposure to IsopropanolRegulatory Toxicology and Pharmacology, 1998
- Alternatives for a Risk Assessment on Chronic Noncancer Effects from Oral Exposure to TrichloroethyleneRegulatory Toxicology and Pharmacology, 1996
- Benchmark Dose Analysis of Developmental Toxicity in Rats Exposed to Boric AcidFundamental and Applied Toxicology, 1996
- Benchmark Dose Workshop: Criteria for Use of a Benchmark Dose to Estimate a Reference DoseRegulatory Toxicology and Pharmacology, 1995
- Calculation of Benchmark Doses from Continuous DataRisk Analysis, 1995
- Dose-Response Assessment for Developmental Toxicity II. Comparison of Generic Benchmark Dose Estimates with No Observed Adverse Effect LevelsFundamental and Applied Toxicology, 1994
- A new method for determining allowable daily intakes*1Fundamental and Applied Toxicology, 1984